A Randomized, Placebo-controlled, Double-blind Trial to Evaluate the Safety and Efficacy of Infliximab in Patients With Active Ulcerative Colitis.

Next Previous
Trial Profile

A Randomized, Placebo-controlled, Double-blind Trial to Evaluate the Safety and Efficacy of Infliximab in Patients With Active Ulcerative Colitis.

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Apr 2010

At a glance

  • Drugs Infliximab (Primary)
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Sponsors Janssen Biotech

    • Most Recent Events

    • 31 Mar 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top